JESSICA LEVY: Open Payments
NPI 1750779351 · MATTHEWS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 30 payments from 15 companies in 2025. Trend: 2023 $38 · 2024 $297 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $125 |
| Lilly USA, LLC | 5 | $92 |
| Exact Sciences Corporation | 3 | $63 |
| Abbott Laboratories | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| PFIZER INC. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Novo Nordisk Inc | 2 | $36 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
Products named: GEMTESA, The Cologuard Plus Collection Kit, GARDASIL 9, SHINGRIX, MOUNJARO, JARDIANCE, SAPIEN 3 Ultra RESILIA, ETERNA.
Industry payments across NC — which companies pay providers there.
